Product and Company News from the 7/22 News Brief

Share this article:

Product News

Biopharmaceutical company QLT announced that it has received final approval from the FDA to market Aczone (dapsone) Gel, for the topical treatment of acne vulgaris.

Company news

Allergan and Pharmacopeia have reached an agreement to research compounds for age-related macular degeneration (AMD). Allergan seeks to strengthen its ocular diseases franchise via possible future acquisitions of Pharmacopeia's novel compounds targeting angiogenesis.

AstraZeneca has agreed to pay up to $340m in cash and conditional milestone payments to Avanir, to license compounds for cardiovascular disease.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in People Moves

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media